Top Markets
Coin of the day
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Rangering i aksjer #14294
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Aksjekurs
$17.15
Sist synkronisert: 2026-08-31
Markedsverdi
$423.01M
Endring (1 dag)
4.67%
Endring (1 år)
112.68%
Land
IN
Handel Novartis India Limited (NOVARTIND)

Kategori

P/S-forhold for Novartis India Limited (NOVARTIND)
P/S-forhold per 2026 TTM: 0
Ifølge Novartis India Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Novartis India Limited fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter